The influence of the intratumor microbiome on pancreatic cancer therapy
Yakut Medical Journal · 28.03.2026 · (1) · 111-115
DOI: 10.25789/ymj.2026.93.23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yakut Medical Journal, online erschienen am 28.03.2026. Verfasst von M. S. Fedorova und 3 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Pancreatic cancer represents one of the most challenging problems in modern oncology. It is characterized by annually increasing incidence rates, extremely low survival rates, and aggressive, often asymptomatic progression, raising the question of the need to search for more effective therapeutic strategies. Currently, microbiome manipulation is considered a powerful auxiliary tool that can enhance the effectiveness of existing treatments. This review summarizes current data on the role of the intratumoral microbiome in pancreatic cancer therapy, considering its influence on treatment efficacy and discussing the potential of targeted impact on microbial communities as an auxiliary method capable of improving patient outcomes.
Zitieren
APA
Fedorova, M. S., Filatova, A. A., Kalinin, D. V., & Pavlov, V. S. (2026). The influence of the intratumor microbiome on pancreatic cancer therapy. Yakut Medical Journal, 111-115. https://doi.org/10.25789/ymj.2026.93.23
Vancouver
Fedorova MS, Filatova AA, Kalinin DV, Pavlov VS. The influence of the intratumor microbiome on pancreatic cancer therapy. Yakut Medical Journal. 2026:111-115. doi:10.25789/ymj.2026.93.23
BibTeX
@article{Fedorova2026,
author = {Fedorova, M. S. and Filatova, A. A. and Kalinin, D. V. and Pavlov, V. S.},
title = {The influence of the intratumor microbiome on pancreatic cancer therapy},
journal = {Yakut Medical Journal},
year = {2026},
number = {1},
pages = {111--115},
doi = {10.25789/ymj.2026.93.23}
}
EUVIMED